scholarly journals A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer

2012 ◽  
Vol 3 ◽  
pp. 145-151 ◽  
Author(s):  
Xin Yao ◽  
Janet Hosenpud ◽  
Christopher R. Chitambar ◽  
John Charlson ◽  
Yee Chung Cheng
Sign in / Sign up

Export Citation Format

Share Document